Search for: "Pharmaceutical Research and Manufacturers of America" Results 181 - 200 of 410
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2013, 9:30 pm by Nicolle Strand
It could, for example, abandon placebo-controlled studies as the gold standard of new drug approval research in favor of comparative effectiveness research, which takes more factors into account and compares new drugs to others already on the market. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch)… [read post]
16 Feb 2011, 10:00 pm by Joe Wallin
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. [read post]
23 Jun 2009, 7:56 am by LaBovick Law
Several organizations such as National League of Cities, Pharmaceutical Research and Manufacturers of America, Chamber of Commerce of the United States of America, and the  Washington Legal Foundation, filed amici curiae Briefs The central players in this case include the Graham County water district from North Carolina and a former secretary at Graham County water district. [read post]
“National critical capabilities” are defined as those identified necessary for supply chains identified pursuant to the supply chain review mandated by Executive Order 14017, including: semiconductor manufacturing materials, large capacity batteries, critical minerals and materials, pharmaceuticals and active pharmaceutical ingredients, and “critical and emerging technologies,” such as artificial intelligence, bioeconomy, and quantum information… [read post]
9 Oct 2020, 8:25 am by Jason Rantanen
Stoll, Maintaining Post-Grant Review Estoppel in the America Invents Act: A Call for Legislative Restraint, 2012 Patently-O Patent Law Journal 1 (Stoll.2012.estoppel.pdf) Paul Morgan, The Ambiguity in Section 102(a)(1) of the Leahy-Smith America Invents Act, 2011 Patently-O Patent Law Journal 29. [read post]
12 Mar 2008, 3:17 pm
Zorina Khan speaks of a "democratization of invention" in America. [read post]
22 Nov 2006, 8:05 am
       The article begins by noting that most "cutting-edge pharmaceutical research is carried out in Western Europe, America, Israel and Japan, all of which have highly educated populations and strong intellectual-property laws. [read post]
26 Mar 2015, 7:44 am by Joe Consumer
  And now it has joined with big PhRMA (the Pharmaceutical Research and Manufacturers of America) to try to weaken the responsibility and liability of the entire pharmaceutical industry. [read post]
28 Apr 2008, 9:03 am
  In fact, many of these studies begin late or do not begin at all.'" Alan Goldhammer, deputy vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America, an industry group:  "Studies can take a long time to begin because of discussions with the FDA over how they should be conducted and difficulties enrolling patients. [read post]
4 Dec 2009, 1:00 pm
A standard safety logo for Web content linking to FDA-approved information about a drug or device was also introduced by the Pharmaceutical Research and Manufacturers of America. [read post]
12 Sep 2019, 5:44 pm by Doyle, Barlow & Mazard PLLC
  Payors such as PBMs and health insurers obtain rebates on prescription drugs from pharmaceutical manufacturers that have actually inflated the price of drugs and stifled the ability of rival drug manufacturers to effectively compete. [read post]
15 Aug 2016, 8:13 am by Michael Grossman
At last count, generics were used to fill roughly 80% of prescriptions in America [read post]
16 May 2010, 7:43 pm by IP Dragon
To no avail, with one exception.Mike Palmedo (Assistent Director of the American University Washington College of Law Program on Information Justice and Intellectual Property (PIJIP) criticized the Pharmaceuticals and Research Manufacturers of America (PhRMA) for criticizing China's government about Active Pharmaceutical Ingredients (API), that the enforcement of health regulations for API, noting that chemical manufacturers may sell and… [read post]
31 Oct 2008, 3:34 pm
” Moving on several years to March 2007, the FDA notified Takeda Pharmaceuticals of North America, Inc. that its diabetes drug, Actos was responsible for increased incidents of bone fractures in women using the drug. [read post]
23 Jan 2019, 4:15 am by Sean Hayes
He worked as an interim general manager/HR manager for oil & gas, new tech, pharmaceutical, franchise, and manufacturing companies. [read post]
28 Dec 2022, 11:42 am by kblocher@hslf.org
We also co-hosted a series of workshops and webinars with industry leaders and regulatory officials from the pharmaceutical, consumer product and chemical sectors to build awareness, trust and acceptance of non-animal approaches throughout Asia, the Americas, Europe and the globe. [read post]